# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
A new reports shows consumers spending more on pet care, including premium products and health care. Chewy and other pet stocks...
The program, led by Lemonade's existing partners, will commence as of July 1, 2024.
To gain an edge, this is what you need to know today.
Jefferies analyst Yaron Kinar maintains Lemonade (NYSE:LMND) with a Underperform and raises the price target from $14 to $16.
Piper Sandler analyst Arvind Ramnani maintains Lemonade (NYSE:LMND) with a Neutral and raises the price target from $17 to $18.